Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0040822 (tremor)
 18,428 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The effects of beta-endorphin and vasoactive intestinal peptide (VIP) on the body shaking response to ice water immersion were observed in anesthetized rats. Intraventricular injection of beta-endorphin markedly inhibited body shaking, but gamma- and alpha-endorphin and methionine-enkephalin showed only slight or little effect. VIP also suppressed the body shaking. The inhibitory effect of beta-endorphin and VIP was blocked by naloxone. When small doses of beta-endorphin and VIP which could not affect the shaking behavior by themselves were administered simultaneously, significant suppression occurred, indicating potentiation of the effect of beta-endorphin by VIP.
 ...
PMID:Suppressive effect of beta-endorphin on body shaking response to ice water immersion and synergistic action of vasoactive intestinal peptide on beta-endorphin in anesthetized rats. 619 39

Bombesin, vasoactive intestinal peptide (VIP) and neurotensin were found to suppress body shaking behavior caused by intracerebroventricular injection of TRH.
 ...
PMID:Effects of bombesin, vasoactive intestinal peptide and neurotensin on TRH-induced body shaking in rats. 642 99

Interaction of cholecystokinin (CCK) with vasoactive intestinal peptide (VIP) in body shaking response to ice-water immersion was observed in pentobarbital-anesthetized rats. Although CCK itself had no influence on the response, VIP suppressed it and this effect of VIP was antagonized by simultaneous administration of sulfated octapeptide of CCK, but not by non-sulfated CCK.
 ...
PMID:Interaction of cholecystokinin with vasoactive intestinal peptide in body shaking response to ice-water immersion in rats. 664 3